City Council voted by a margin of 6-4 Monday night to reduce the licensing renewal fee for cannabis retail stores from $10,000 to $85

The fee applies to the city’s seven retail cannabis outlets allowed under provincial legislation.

This is a further decrease from the original $500 recommended by city staff, the result of a motion introduced at a committee meeting August 12. It puts the renewal fee that cannabis businesses pay in line with most other types of businesses in the city.

In discussion Monday, Coun. Ann Iwanchuk called the $500 “arbitrary.”

“The vast majority of businesses pay $85 dollars, I feel like this is a way of singling out this one particular business,” she said. “We’re not the moral authority here.”

Extraction cannabis company MediPharm Labs (MEDIF) has been accelerating its upward growth trajectory at the right time, as Canada is poised to give the go ahead for derivatives to be sold in the country.

The good news is the company has managed to boost revenue significantly while turning a small profit, before the regulations go into effect on October 17, 2019, and distribution to dispensaries starting in the middle of December 2019.

Two of the most popular derivatives expected to generate strong revenue are edibles and infused drinks. Other derivatives include concentrates, gel caps, tincture oil and vape pens, among others.

The Global “Marijuana Cigarette Market” research 2019 highlights the major details and provides in-depth analysis of the market along with the future growth, prospects and Industry demands analysis explores with the help of complete report with 90 Pages, figures, graphs and table of contents to analyze the situations of global Marijuana Cigarette Market and Assessment to 2023.

Global  Industrial Hemp Market industry offers an in-depth scenario which is bifurcate according to manufacturers, Industrial Hemp product type, applications with technological advancement and regions. This segmentation will offers a decisive outlook of the Industrial Hemp industry. The overview includes the market growth opportunities, trends, Industrial Hemp constraints, drivers of the market. The report also provides forecast data based on previous years and present market environment and develpoment.

Canopy Growth shares rose after an analyst at Seaport Global Securities upgraded the Canadian pot maker on expectations the recreational marijuana market will give it a boost.

Analyst Brett Hundley upgraded Canopy to buy from neutral and hiked his price target on the stock to $31 per share. That’s a 24.5% upside from Friday’s close of $24.89. The stock traded up 1.9% at $25.37 in the premarket.

Last year, there was no shortage of marijuana milestones . We watched Canada become the first industrialized country in the world to legalize recreational marijuana, had the U.S. Food and Drug Administration (FDA) approve the very first cannabis-derived drug, and saw support for legalization among the U.S.

You've no doubt heard that the global cannabis market is poised to skyrocket. Thirty-three U.S. states have legalized medical cannabis, along with over 40 countries. Canada's recreational cannabis market is picking up momentum, while 11 U.S. states have legalized recreational pot, with more potentially on the way. Some observers predict an annual global cannabis market of $150 billion or more.

Do you feel like you’ve missed out on the massive gains reaped by early investors in Canada’s marijuana stocks? With marijuana stocks tanking in tandem over the past few months, is it time for wary investors to jump in?

Up until the last few months, cannabis stocks had been on a tear. Cronos Group, for example, rewarded its early investors with a gain of 1,200% over the past two years, until the downturn began.

If you’d been smart or lucky enough to have been an early investor in Canopy Growth, the results would have been even more impressive. You would have seen your investment grow 3,250% before the pullback.

For years, cannabis stocks have been showing investors the green. Early investors in some of the most popular pot stocks are likely sitting on triple-digit or quadruple-digit gains today, with more than a dozen cannabis stocks gaining at least 70% during the first quarter.

However, the green rush has come to a crashing halt since April began. Few cannabis stocks are near their 2019 highs, with most registering double-digit losses during the month of July.

Thanks to some quirky regulations, there are some odd realities for cannabis stocks . For example, Canadian cannabis producerAphria (NYSE: APHA) is listed on the New York Stock Exchange (NYSE) while U.S. cannabis operator Green Thumb Industries(OTC: GTBIF) is listed on the Canadian Securities Exchange (CSE) and is available in the U.S. only on an over-the-counter market.

Because it doesn't have as much visibility, some investors could be overlooking Green Thumb Industries. But is it a better cannabis stock to buy right than Aphria? Here's how the two stocks stack up against each other.